findmyKOL

Ilo Leppik, MD

Basic profile

University of Minnesota

ORCIDNPI
RegionMinneapolis, MN · MidwestSpecialtyNeurologyFocusNeurology
Last active 2011findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding1985–2011Why? →

Ilo Leppik is a Neurology physician affiliated with University of Minnesota. OpenAlex indexes 329 publications with 12,165 citations (h-index 59).

Overview

Scholarship

indexed output and impact (OpenAlex)
329publications

Distinct works indexed by OpenAlex, matched via ORCID.

12,165citations

Total citations across indexed works.

59h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5NIH grants · 1985–2011

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    96.6%
    Other antiepileptics25.4%
    Levetiracetam59%Lacosamide13%Epidiolex10%Keppra9%Topiramate6%Briviact3%
    Part D<11 patients
    Anti-epileptic Agent18.5%
    Zonisamide44%Felbamate33%Oxcarbazepine12%Primidone6%Ethosuximide3%Felbatol3%
    Part D<11 patients

    + 9 more classes in this area

  • Metabolism & gastrointestinal

    2.1%
    Carnitine Analog2.1%
    Levocarnitine100%
    Part D<11 patients
  • Sensory organs

    0.7%
    Carbonic Anhydrase Inhibitor0.7%
    Acetazolamide100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

5 NIH research awards on record, funded 19852011 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”